PMID- 20361487
OWN - NLM
STAT- MEDLINE
DCOM- 20100603
LR  - 20100405
IS  - 1405-9940 (Print)
IS  - 1665-1731 (Linking)
VI  - 79 Suppl 2
DP  - 2009 Dec
TI  - [Clinical benefit in cardiac resynchronization].
PG  - 71-4
AB  - Despite the improvement in pharmacologic treatment of heart failure, many 
      patients continue to have severe persistent symptoms, and their prognosis remains 
      poor. One of the most recent advances in heart failure management is the concept 
      of cardiac resynchronization therapy (CRT). Large clinical trials have 
      demonstrated morbidity and mortality benefits of CRT in patients with moderate to 
      severe drug refractory heart failure (New York Heart Association [NYHA] 
      functional class III or IV), and ejection fraction < or = 35% with QRS duration > 
      or = 120 ms.
FAU - Guevara-Valdivia, Milton E
AU  - Guevara-Valdivia ME
AD  - Servicio de Electrofisiologia y Estimulacion Cardiaca, UMAE, Hospital de 
      Especialidades Dr. Antonio Fraga Mouret, CMN La Raza. IMSS, Mexico, D. F. 
      mylton@yahoo.com
LA  - spa
PT  - English Abstract
PT  - Journal Article
TT  - Beneficios clinicos de la resincronizacion cardiaca.
PL  - Mexico
TA  - Arch Cardiol Mex
JT  - Archivos de cardiologia de Mexico
JID - 101126728
SB  - IM
MH  - *Cardiac Pacing, Artificial
MH  - Heart Failure/*therapy
MH  - Humans
MH  - Treatment Outcome
EDAT- 2010/04/07 06:00
MHDA- 2010/06/04 06:00
CRDT- 2010/04/06 06:00
PHST- 2010/04/06 06:00 [entrez]
PHST- 2010/04/07 06:00 [pubmed]
PHST- 2010/06/04 06:00 [medline]
PST - ppublish
SO  - Arch Cardiol Mex. 2009 Dec;79 Suppl 2:71-4.